The Manufacturers Life Insurance Company Lowers Holdings in Molina Healthcare, Inc $MOH

The Manufacturers Life Insurance Company lowered its position in Molina Healthcare, Inc (NYSE:MOH) by 85.2% during the 1st quarter, Holdings Channel reports. The firm owned 22,896 shares of the company’s stock after selling 131,664 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Molina Healthcare were worth $3,052,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Torren Management LLC purchased a new stake in Molina Healthcare in the fourth quarter worth about $26,000. MUFG Securities EMEA plc purchased a new position in Molina Healthcare during the 2nd quarter valued at about $48,000. Quarry LP purchased a new position in Molina Healthcare during the 4th quarter valued at about $32,000. Triumph Capital Management raised its holdings in shares of Molina Healthcare by 4,625.0% in the 4th quarter. Triumph Capital Management now owns 189 shares of the company’s stock valued at $33,000 after purchasing an additional 185 shares in the last quarter. Finally, Physician Wealth Advisors Inc. raised its holdings in shares of Molina Healthcare by 1,250.0% in the 1st quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock valued at $29,000 after purchasing an additional 200 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, May 2nd. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a report on Wednesday, April 29th. Morgan Stanley increased their target price on Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Robert W. Baird boosted their price target on Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Finally, Cantor Fitzgerald restated a “neutral” rating on shares of Molina Healthcare in a research note on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $202.44.

Molina Healthcare Price Performance

Shares of MOH opened at $196.65 on Friday. The company has a market cap of $10.27 billion, a price-to-earnings ratio of -1,092.43, a price-to-earnings-growth ratio of 27.49 and a beta of 0.75. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.95. The company has a 50 day moving average of $209.25 and a two-hundred day moving average of $177.81.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.12. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The business had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. During the same period in the previous year, the company earned $5.48 earnings per share. The business’s revenue for the quarter was down 4.8% on a year-over-year basis. As a group, analysts predict that Molina Healthcare, Inc will post 5.29 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This represents a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is owned by insiders.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.